Connection

Miguel Abboud to Benzaldehydes

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Benzaldehydes.
Miguel Abboud
Connection Strength
0.406
Benzaldehydes
  1. Voxelotor for the treatment of sickle cell disease in pediatric patients. Expert Rev Hematol. 2022 06; 15(6):485-492.
    View in: PubMed
    Score: 0.197
  2. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
    View in: PubMed
    Score: 0.160
  3. Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11?years. Pediatr Blood Cancer. 2022 08; 69(8):e29716.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.